Search

Author/Creator Bischoff, Helge G

1. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Issue 3 (March 2020)

Authors:
Garassino, Marina C; Gadgeel, Shirish; Esteban, Emilio; Felip, Enriqueta; Speranza, Giovanna; Domine, Manuel; Hochmair, Maximilian J; Powell, Steven; Cheng, Susanna Yee-Shan; Bischoff, Helge G; Peled, Nir; Reck, Martin; Hui, Rina; Garon, Edward B; Boyer, Michael; Wei, Ziwen; Burke, Thomas; Pietan...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 3(2020)
Page Start:
387
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search